Fibrosis: From Bench to Bedside, Proceedings of the Keystone Symposia on Molecular and Cellular Biology, March 23-28, 2014, Keystone, Colorado. Silverthorne, CO: Keystone Symposia, 2014 Mar; :96
The production of multi-walled carbon nanotubes (MWCNT) has been significantly increased in recent decades due to their widespread applications, which has led to a concern regarding their impacts on human health because of the similarities of MWCNT to asbestos fibers. Recently, pulmonary fibrosis was associated with the major effects of MWCNT on health, but with limited progress in understanding the extent of MWCNT exposure in initiation and progression of lung fibrosis and in identifying the molecules that contribute to this pathologic consequence. Here, we showed MWCNT were a potent fibrotic agent that induced rapid-onset fibrosis upon single exposure to low doses 7 days post-exposure in C57BL/6 mice, indicated by histological analysis and increased expression of fibrosis marker genes, such as aSMA and Col1a1 . The MWCNT exposure elicited significant inflammatory response evidenced by inflammatory infiltration in the lungs and markedly increased PMN count and lactate dehydrogenase activity in the BAL from fibrotic lungs. To understand the underlying mechanism, we determined the expression of several groups of molecules including the genes involved in inflammatory immune responses, extracellular matrix remodeling and cytotoxicity, by PCR array analysis. Elevated gene expression was verified in the lungs and in fibrotic foci, which occurred mainly in the regions where MWCNT were distributed, including proinflammatory cytokines and matrix remodeling enzymes. Molecular mechanism studies were performed in alveolar macrophages and lung fibroblasts to understand the relation between inflammation and fibrosis under MWCNT exposure, and the signaling pathways involved in both processes. Results from this study will contribute to both general concept on fibrogenesis and mechanism identification specific to MWCNT-initiated fibrosis.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.